SCHEMBL21966471

SCHEMBL21966471

c1ccc(N(c2ccccc2)c2ccc3c(c2)sc2cccc(N(c4ccccc4)c4ccc5c(c4)sc4ccccc45)c23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GPR3 P46089 1/20 0.39
TDP1 Q9NUW8 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
CYP1A2 P05177 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
POLB P06746 2/20 0.31
APP P05067 1/20 0.31
MEN1 O00255 1/20 0.31
DUSP3 P51452 1/20 0.31
BLM P54132 1/20 0.31
PTPN5 P54829 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21966038 1.00 MAPT (0.41) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL24701079 0.96 MAPT (0.38) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19660624 0.96 MAPT (0.38) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19656437 0.96 MAPT (0.38) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL21968662 0.95 ALDH1A1 (0.37) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL25890460 0.95 ALDH1A1 (0.37) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL21966470 0.95 ALDH1A1 (0.37) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL21966037 0.95 ALDH1A1 (0.37) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19656399 0.95 ALDH1A1 (0.37) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL19801828 0.95 MAPT (0.37) MAPTALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200176685-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-06-04 US disclosed
US-20200144510-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-05-07 US disclosed
US-20200144508-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200144508-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD1, OCIAD2, OR10J3 MAPT 2375/4885ALDH1A1 49/4885HPGD 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.